More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices ... The technology firm's work with Dexcom involves developing ...

Health care apps like MyChart, mySugr, GoodRx, and Smoke Free can enhance patient care through accessibility, convenience, ...

Dexcom has seen the potential in combining its glucose measuring capabilities with ŌURA’s technology and has invested $75m in ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Dexcom and ŌURA announce a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health ...

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.

Next, we see Drury doing a routine on a trampoline while wearing one of Dexcom’s continuous glucose monitors (CGMs). In a voice-over, Jonas says, “if it feels like a diagnosis has turned your ...

DexCom, Inc. (NASDAQ:DXCM) is a medical device company, which focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the US and internationally.

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company specializing in designing, developing, and commercializing continuous glucose ...